Almost two in five physicians suffered moral distress in the two weeks leading up to their being asked about it by researchers. That was a markedly larger slice than the team observed in the general U.S. working population. 

New findings suggest that the procedure offers effective local control and a favorable safety profile for patients with medically inoperable stage 1A non-small cell lung cancer.

Gadolinium-153, or Gd-153, is routinely used to calibrate nuclear imaging equipment. It has been in short supply since 2023 when global distribution of the radioisotope came to a halt. 

The report on the financials comes from Mississippi Today. University of Mississippi Medical Center said it’s still processing paper backups and has extended clinic hours to address the backlog of elective surgeries and bring revenue back up to expectations. The attack happened in February and caused non-emergency operations at the health system to shut down for nine days. 

In a lawsuit seeking class action status, a woman identified as “P.M.” said she began using the website for Kisqali, a Novartis breast cancer treatment, in late 2024 shortly after being issued a prescription. Unbeknownst to her, sensitive data she shared when seeking a discount may have been shared with advertisers.

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

The specialty is moving toward expanded use of fractional flow reserve CT and AI analysis of coronary CT angiography exams as a standard of care.

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities. 

The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States. 

Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents.